ATE466285T1 - Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers - Google Patents
Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpersInfo
- Publication number
- ATE466285T1 ATE466285T1 AT04734768T AT04734768T ATE466285T1 AT E466285 T1 ATE466285 T1 AT E466285T1 AT 04734768 T AT04734768 T AT 04734768T AT 04734768 T AT04734768 T AT 04734768T AT E466285 T1 ATE466285 T1 AT E466285T1
- Authority
- AT
- Austria
- Prior art keywords
- cirrhosis
- diagnosis
- liver
- antibody specific
- human proto
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
- B23K26/00—Working by laser beam, e.g. welding, cutting or boring
- B23K26/02—Positioning or observing the workpiece, e.g. with respect to the point of impact; Aligning, aiming or focusing the laser beam
- B23K26/035—Aligning the laser beam
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
- B23K26/00—Working by laser beam, e.g. welding, cutting or boring
- B23K26/20—Bonding
- B23K26/21—Bonding by welding
- B23K26/22—Spot welding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/08—Hepato-biliairy disorders other than hepatitis
- G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Mechanical Engineering (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Plasma & Fusion (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030033308A KR100545064B1 (ko) | 2003-05-26 | 2003-05-26 | 인간 원암단백질에 특이적인 항체를 포함하는 간경변증진단 키트 |
PCT/KR2004/001242 WO2004104598A1 (en) | 2003-05-26 | 2004-05-25 | Diagnostic kit for liver cirrhosis compring an antibody specific for human protooncogenic protein |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE466285T1 true ATE466285T1 (de) | 2010-05-15 |
Family
ID=36806165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04734768T ATE466285T1 (de) | 2003-05-26 | 2004-05-25 | Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers |
Country Status (10)
Country | Link |
---|---|
US (1) | US20070141633A1 (de) |
EP (1) | EP1636587B1 (de) |
JP (1) | JP2007502427A (de) |
KR (1) | KR100545064B1 (de) |
CN (1) | CN1795388A (de) |
AT (1) | ATE466285T1 (de) |
CA (1) | CA2526661A1 (de) |
DE (1) | DE602004026869D1 (de) |
TW (1) | TW200510725A (de) |
WO (1) | WO2004104598A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008006806A1 (de) * | 2007-05-30 | 2008-12-11 | Frimtec Gmbh | Immunologisches Verfahren und Testkit zum Ermitteln des Progesterongehalts einer Probe und Vorrichtung hierfür |
CN102401831B (zh) * | 2011-11-14 | 2013-10-30 | 北京正旦国际科技有限责任公司 | 一种肝硬化竞争性酶联免疫检测试剂盒及其检测方法 |
CN102520175B (zh) * | 2011-11-14 | 2014-04-16 | 北京正旦国际科技有限责任公司 | 一种肝癌多肽标志物抗原竞争性酶联免疫检测试剂盒 |
KR102242999B1 (ko) | 2019-11-05 | 2021-04-21 | 중앙대학교 산학협력단 | 초기 간경변 진단용 조성물 및 이를 이용한 초기 간경변 진단 방법 |
CN114088939A (zh) * | 2021-11-19 | 2022-02-25 | 中国人民解放军陆军军医大学第一附属医院 | 一种原发性胆汁性胆管炎诊断用分子标志物及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0973941A1 (de) * | 1997-04-07 | 2000-01-26 | Institut Pasteur | Diagnostische mittel, geeignet für die voraussagende abschätzung einer erkrankung an humanem hepatozellulärem karzinom (hcc), sowie diagnostische verfahren unter verwendung derselben |
RU2203497C2 (ru) * | 1997-09-24 | 2003-04-27 | Санкио Компани Лимитед | Способ диагностики метаболических костных заболеваний |
US5976849A (en) * | 1998-02-05 | 1999-11-02 | Zeneca Limited | Human E3 ubiquitin protein ligase |
KR100426453B1 (ko) * | 2000-11-28 | 2004-04-13 | 김진우 | 인간 자궁경부암 2 원암 유전자 및 이에 의해 코딩되는단백질, 이를 포함하는 발현벡터 및 이 벡터로 형질전환된세포 |
-
2003
- 2003-05-26 KR KR1020030033308A patent/KR100545064B1/ko active IP Right Grant
-
2004
- 2004-05-25 CN CNA2004800145984A patent/CN1795388A/zh active Pending
- 2004-05-25 JP JP2006532061A patent/JP2007502427A/ja active Pending
- 2004-05-25 AT AT04734768T patent/ATE466285T1/de not_active IP Right Cessation
- 2004-05-25 WO PCT/KR2004/001242 patent/WO2004104598A1/en active Application Filing
- 2004-05-25 CA CA002526661A patent/CA2526661A1/en not_active Abandoned
- 2004-05-25 EP EP04734768A patent/EP1636587B1/de not_active Expired - Lifetime
- 2004-05-25 DE DE602004026869T patent/DE602004026869D1/de not_active Expired - Lifetime
- 2004-05-25 US US10/558,667 patent/US20070141633A1/en not_active Abandoned
- 2004-05-26 TW TW093114863A patent/TW200510725A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004104598A1 (en) | 2004-12-02 |
EP1636587A4 (de) | 2006-07-12 |
US20070141633A1 (en) | 2007-06-21 |
KR20040101633A (ko) | 2004-12-03 |
CN1795388A (zh) | 2006-06-28 |
JP2007502427A (ja) | 2007-02-08 |
TW200510725A (en) | 2005-03-16 |
EP1636587A1 (de) | 2006-03-22 |
DE602004026869D1 (de) | 2010-06-10 |
CA2526661A1 (en) | 2004-12-02 |
EP1636587B1 (de) | 2010-04-28 |
KR100545064B1 (ko) | 2006-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE425461T1 (de) | Diagnose von hepatozellulärem karzinom | |
ATE289685T1 (de) | Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben | |
ATE520026T1 (de) | Sequenzielle analyse biologischer proben | |
MX2007005053A (es) | Metodo para evaluar la enfermedad de alzheimer y reactivo de diagnostico. | |
MX2007014815A (es) | Metodos de inmunoanalisis mejorados. | |
ATE360809T1 (de) | Schnelltest für biologische substanzen mittels ftir | |
ATE524742T1 (de) | Sequenzielle analyse biologischer proben mit zwischenbleichung eines fluoreszenzdetektors | |
HK1062032A1 (en) | Mediator stabilized reagent compositions and methods for their use in electrochemical analyte detection assays | |
ATE503846T1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
DE60129151D1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
PH12020551371A1 (en) | Assays to detect neurodegeneration | |
ATE469351T1 (de) | Turbidimetrischer immunoassay zur beurteilung von humanem cystatin c | |
ATE370414T1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
NZ592819A (en) | Thyroid analyte detection and measurement | |
DE60325107D1 (de) | Verfahren und kit zum quantitativen und/oder qualitativen nachweis von komponenten in einer probe | |
CA2586654A1 (en) | Use of asc as a marker for colorectal cancer | |
ATE466285T1 (de) | Diagnose von leberzirrhose mittels eines für menschliches protoonkogenes protein spezifischen antikörpers | |
DE602005010548D1 (de) | Verbessertes verfahren zur diagnose des akuten koronarsyndroms | |
ATE470152T1 (de) | Diagnostikverfahren mittels messungen der antiglykan-antikörper-spiegeln | |
DE60220288D1 (de) | Bestimmung der Genauigkeit eines Probevolumens in Biosensoren | |
HUP0100948A2 (hu) | Antitest kompeticiós teszt (AKT) P-glikoprotein és egyéb sejtfelszíni receptorok, pumpák és fehérjék konformáció-változásainak kvalitatív, illetve konformáció-függő kvantitatív kimutatására és annak alkalmazásai | |
ATE359516T1 (de) | Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs | |
ATE393393T1 (de) | Verwendung des proteins spee als marker für brustkrebs | |
ATE410691T1 (de) | Verwendung des proteins proteasome aktivator untereinheit 3 als marker für kolorektale karzinome | |
RU2004139173A (ru) | Способ диагностики дисбактериоза кишечника |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |